The development of L-asparaginase as a cancer therapeutic starts with Kidd in 1953 who detected an anti-lymphoma effect of the guinea pig serum, which was later revealed by Broome to be related to its L-asparaginase activity3, 4. Here, ASPG is linked to lymphoma.